SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Sleegers K) "

Sökning: WFRF:(Sleegers K)

  • Resultat 41-47 av 47
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
41.
  •  
42.
  •  
43.
  •  
44.
  •  
45.
  •  
46.
  • Visser, P. J., et al. (författare)
  • Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease
  • 2022
  • Ingår i: Molecular Neurodegeneration. - : Springer Science and Business Media LLC. - 1750-1326. ; 17:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer's disease (AD) and is considered to result from neurodegeneration. T-tau levels, however, can be increased in very early disease stages, when neurodegeneration is limited, and can be normal in advanced disease stages. This suggests that t-tau levels may be driven by other mechanisms as well. Because tau pathophysiology is emerging as treatment target for AD, we aimed to clarify molecular processes associated with CSF t-tau levels. Methods We performed a proteomic, genomic, and imaging study in 1380 individuals with AD, in the preclinical, prodromal, and mild dementia stage, and 380 controls from the Alzheimer's Disease Neuroimaging Initiative and EMIF-AD Multimodality Biomarker Discovery study. Results We found that, relative to controls, AD individuals with increased t-tau had increased CSF concentrations of over 400 proteins enriched for neuronal plasticity processes. In contrast, AD individuals with normal t-tau had decreased levels of these plasticity proteins and showed increased concentrations of proteins indicative of blood-brain barrier and blood-CSF barrier dysfunction, relative to controls. The distinct proteomic profiles were already present in the preclinical AD stage and persisted in prodromal and dementia stages implying that they reflect disease traits rather than disease states. Dysregulated plasticity proteins were associated with SUZ12 and REST signaling, suggesting aberrant gene repression. GWAS analyses contrasting AD individuals with and without increased t-tau highlighted several genes involved in the regulation of gene expression. Targeted analyses of SNP rs9877502 in GMNC, associated with t-tau levels previously, correlated in individuals with AD with CSF concentrations of 591 plasticity associated proteins. The number of APOE-e4 alleles, however, was not associated with the concentration of plasticity related proteins. Conclusions CSF t-tau levels in AD are associated with altered levels of proteins involved in neuronal plasticity and blood-brain and blood-CSF barrier dysfunction. Future trials may need to stratify on CSF t-tau status, as AD individuals with increased t-tau and normal t-tau are likely to respond differently to treatment, given their opposite CSF proteomic profiles.
  •  
47.
  • Zhang, Y. T., et al. (författare)
  • Predicting AT(N) pathologies in Alzheimer's disease from blood-based proteomic data using neural networks
  • 2022
  • Ingår i: Frontiers in Aging Neuroscience. - : Frontiers Media SA. - 1663-4365. ; 14
  • Tidskriftsartikel (refereegranskat)abstract
    • Background and objective: Blood-based biomarkers represent a promising approach to help identify early Alzheimer's disease (AD). Previous research has applied traditional machine learning (ML) to analyze plasma omics data and search for potential biomarkers, but the most modern ML methods based on deep learning has however been scarcely explored. In the current study, we aim to harness the power of state-of-the-art deep learning neural networks (NNs) to identify plasma proteins that predict amyloid, tau, and neurodegeneration (AT[N]) pathologies in AD.Methods: We measured 3,635 proteins using SOMAscan in 881 participants from the European Medical Information Framework for AD Multimodal Biomarker Discovery study (EMIF-AD MBD). Participants underwent measurements of brain amyloid 13 (A13) burden, phosphorylated tau (p-tau) burden, and total tau (t-tau) burden to determine their AT(N) statuses. We ranked proteins by their association with A13, p-tau, t-tau, and AT(N), and fed the top 100 proteins along with age and apolipoprotein E (APOE) status into NN classifiers as input features to predict these four outcomes relevant to AD. We compared NN performance of using proteins, age, and APOE genotype with performance of using age and APOE status alone to identify protein panels that optimally improved the prediction over these main risk factors. Proteins that improved the prediction for each outcome were aggregated and nominated for pathway enrichment and protein-protein interaction enrichment analysis.Results: Age and APOE alone predicted A13, p-tau, t-tau, and AT(N) burden with area under the curve (AUC) scores of 0.748, 0.662, 0.710, and 0.795. The addition of proteins significantly improved AUCs to 0.782, 0.674, 0.734, and 0.831, respectively. The identified proteins were enriched in five clusters of AD-associated pathways including human immunodeficiency virus 1 infection, p53 signaling pathway, and phosphoinositide-3-kinase-protein kinase B/Akt signaling pathway.Conclusion: Combined with age and APOE genotype, the proteins identified have the potential to serve as blood-based biomarkers for AD and await validation in future studies. While the NNs did not achieve better scores than the support vector machine model used in our previous study, their performances were likely limited by small sample size.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 41-47 av 47
Typ av publikation
tidskriftsartikel (44)
konferensbidrag (3)
Typ av innehåll
refereegranskat (40)
övrigt vetenskapligt/konstnärligt (7)
Författare/redaktör
Sleegers, K (42)
Van Broeckhoven, C (32)
Engelborghs, S. (29)
Lleó, A. (27)
Graff, C (22)
Vandenberghe, R (21)
visa fler...
Clarimón, J. (18)
Tsolaki, M (17)
Nacmias, B (17)
Pastor, P (16)
Sánchez-Valle, R (16)
Sorbi, S (16)
de Mendonça, A (16)
De Deyn, PP (15)
Ramirez, A (14)
Borroni, B. (14)
Lovestone, S (13)
Gelpi, E (13)
Diehl-Schmid, J (13)
Popp, J (13)
van der Zee, J (13)
Ruiz, A. (12)
Zetterberg, Henrik, ... (12)
Padovani, A (12)
Ghidoni, R (12)
Jessen, F (12)
Benussi, L (12)
Binetti, G (12)
Williams, J (11)
Fortea, J. (11)
Scheltens, P (11)
Ingelsson, Martin (10)
Hiltunen, M (10)
Amouyel, P (10)
Alvarez, V (10)
Bertram, L (10)
Grenier-Boley, B (10)
Bossù, P (10)
Sims, R (10)
Boada, M. (9)
Spalletta, G (9)
Soininen, H (9)
Maier, W (9)
Galimberti, D (9)
Visser, P. J. (9)
Bellenguez, C (9)
Küçükali, F (9)
Mayeux, R (9)
Pasquier, F (9)
Martinez-Lage, P. (9)
visa färre...
Lärosäte
Karolinska Institutet (37)
Göteborgs universitet (14)
Stockholms universitet (12)
Uppsala universitet (10)
Umeå universitet (3)
Örebro universitet (3)
visa fler...
Linköpings universitet (2)
Kungliga Tekniska Högskolan (1)
Högskolan Väst (1)
Jönköping University (1)
Lunds universitet (1)
visa färre...
Språk
Engelska (47)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (24)
Samhällsvetenskap (5)
Naturvetenskap (4)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy